Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 05 Aug 2021
MT-3921 granted FDA fast track designation for treatment of spinal cord injury
4 August 2021 - Mitsubishi Tanabe Pharma announced today that Mitsubishi Tanabe Pharma Development America has received fast track designation ...
Posted by Michael Wonder on 05 Aug 2021
COVID-19 vaccine weekly safety report (5 August 2021)
5 August 2021 - Three additional cases of blood clots with low blood platelets have been assessed as thrombosis with thrombocytopenia ...
Posted by Michael Wonder on 05 Aug 2021
Lupus drug will be ‘game changer’
5 August 2021 - The first targeted treatment for the debilitating auto-immune condition lupus could soon be available in Australia after ...
Posted by Michael Wonder on 05 Aug 2021
Lymphoma patients to benefit from new cancer therapy
5 August 2021 - Australians suffering from a rare type of blood cancer will now have access to a highly specialised ...
Posted by Michael Wonder on 05 Aug 2021
Health Canada approves Arazlo lotion for acne vulgaris treatment
4 August 2021 - Bausch Health said that Health Canada has approved the Notice of Compliance for Arazlo ( tazarotene) ...
Posted by Michael Wonder on 04 Aug 2021
How to balance the patient voice atop the shifting plates of HTA
3 August 2021 - The tectonic plates of healthcare technology assessment have shifted – but where does the patient voice ...
Posted by Michael Wonder on 04 Aug 2021
ECDC and EMA update on COVID-19
4 August 2021 - Full vaccination is key to protecting against serious COVID-19, including disease caused by the Delta variant. ...
Posted by Michael Wonder on 04 Aug 2021
Court topples Canadian ruling that one of world's most expensive drugs is excessively priced
3 August 2021 - Soliris was originally approved to treat two blood disorders affecting about 180 Canadians, with the list price ...
Posted by Michael Wonder on 04 Aug 2021
New CAR T-cell therapy option now available in Australia for patients with aggressive blood cancer
5 August 2021 - Eligible patients can now access Yescarta through Peter MacCallum Cancer Centre, Melbourne and Royal Brisbane and Women’s ...
Posted by Michael Wonder on 04 Aug 2021
Federal watchdog will review the controversial FDA approval of Biogen’s Alzheimer’s drug
4 August 2021 - The federal watchdog at the Department of Health and Human Services will review the process used ...
Posted by Michael Wonder on 04 Aug 2021
Cerus Corporation announces CMS has granted new technology add-on payment for INTERCEPT fibrinogen complex
3 August 2021 - New technology add-on payment provides incremental reimbursement under CMS’ Inpatient Prospective Payment System for INTERCEPT Fibrinogen Complex. ...
Posted by Michael Wonder on 04 Aug 2021
New collaboration between NICE and The Academic Health Science Network will help embed innovations into the healthcare system for the benefit of patients
4 August 2021 - The agreement will draw on the strengths, skills, and resources of both organisations in order to seize ...
Posted by Michael Wonder on 04 Aug 2021
Kestra Medical Technologies receives FDA premarket approval for ASSURE wearable cardioverter defibrillator
3 August 2021 - Kestra Medical Technologies announced today that the company has received U.S. FDA premarket approval for the ASSURE ...
Posted by Michael Wonder on 04 Aug 2021
Collecting patient reported outcomes in cancer clinical trials
3 August 2021 - To help patients with cancer learn more about how treatment may affect their quality of life, the ...
Posted by Michael Wonder on 04 Aug 2021
FDA reportedly hopes to fully approve Pfizer’s Covid vaccine by Labor Day
3 August 2021 - Federal regulators are aiming to grant full approval to Pfizer’s coronavirus vaccine by early September, the New ...